News

Psychedelic Science Announces Sessions and Select Featured Speakers for Science and Research Tracks for 2023 Conference

Dr. Roland Griffiths Announced to Lead Discussions on the Science and Research of Psychedelics Featured Speakers Includes Dr. Matthew Johnson,…

2 years ago

Humacyte, JDRF Collaborating to Develop Insulin-Producing Biovascular Pancreas to Treat Type 1 Diabetes

NEW YORK, N.Y. and DURHAM, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a biotechnology company pioneering…

2 years ago

Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that…

2 years ago

ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences

PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the…

2 years ago

Smart for Life Releases Video Showcasing New High Protein Ice Cream

Dr. Sasson Moulavi Discusses Benefits of Smart for Life’s Unique New Product CategoryMIAMI, April 26, 2023 (GLOBE NEWSWIRE) -- Smart…

2 years ago

AUM Biosciences to Participate in Inaugural EF Hutton Global Conference

SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company…

2 years ago

ContraFect Announces First Patient Dosed in the Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee

YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…

2 years ago

Allied Corp Signs Joint Venture With Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets

KELOWNA, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID), a leading cannabis…

2 years ago

T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference

LEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

2 years ago

Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

2 years ago